299912-77-9 Usage
Description
6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one is a chemical compound characterized by a benzofuran ring with a tert-butyldimethylsilyl group attached to an oxygen atom. This structure endows it with unique properties that make it valuable in various applications across different fields.
Uses
Used in Organic Synthesis:
6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one is utilized as a protecting group for alcohols in organic synthesis. It facilitates selective manipulation of reactive functional groups within a molecule, which is crucial for the synthesis of complex organic compounds.
Used in Pharmaceutical Preparation:
6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one plays a significant role in the preparation of various pharmaceuticals and bioactive compounds. Its ability to protect and selectively modify functional groups makes it an essential component in the development of new drugs.
Used in Materials Science:
6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one also has potential applications in materials science. Its unique structure and properties can contribute to the development of new materials with specific characteristics for various uses.
Used as a Reagent in Organic Chemistry Reactions:
Furthermore, 6-((tert-butyldimethylsilyl)oxy)benzofuran-3(2H)-one serves as a reagent in a range of organic chemistry reactions. Its versatility allows it to participate in multiple reaction types, broadening its utility in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 299912-77-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,9,1 and 2 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 299912-77:
(8*2)+(7*9)+(6*9)+(5*9)+(4*1)+(3*2)+(2*7)+(1*7)=209
209 % 10 = 9
So 299912-77-9 is a valid CAS Registry Number.
299912-77-9Relevant articles and documents
PD-1/PD-L1 small-molecule inhibitor and preparation method and application thereof
-
Paragraph 0021; 0229; 0230; 0231, (2019/05/08)
The invention discloses a PD-1/PD-L1 small-molecule inhibitor and a preparation method and application thereof. Specifically, the invention discloses a compound with the structure shown in the formulaL, a stereoisomer or a tautomer thereof, or pharmaceutically acceptable salts or hydrates or solvates thereof, and please see the specification for specific definitions. The compound has excellent effects for restraining PD-1/PD-L1. Please see the specification for the formula.
LFA-1 INHIBITOR AND POLYMORPH THEREOF
-
Paragraph 00131; 00132; 00133; 00134; 00135, (2014/02/16)
Methods of preparation and purification of a compound, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA -1 mediated diseases are also disclosed.
MODULATORS OF CFTR
-
Page/Page column 77, (2009/01/20)
Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating CFTR mediated diseases using compounds of the present invention.